NEOLIFE: Standard Growth of 3.3%, but Return to Net Loss in 2025
The European leader in sustainable bio-composites reports a standard revenue growth of 3.3% in 2025, driven by acceleration in the second half of the year. However, this commercial progress comes with a net loss of €117K, compared to a profit of €473K the previous year, a direct consequence of pre-emptive investments to deploy its strategic plan for 2026-2030.
Sustained Growth Amidst Market Slowdown
NEOLIFE demonstrates considerable resilience in a slowing sustainable construction market. The standard revenue, excluding eco-material sales, grew by 3.3% to reach €10.9M in 2025. More notably, there was an acceleration observed in the second half of the year, with standard revenues of €5.9M compared to €5.0M in the first half, indicating an improvement in commercial conditions amidst a persistent slowdown in construction starts. The total accounting revenue amounted to €12.4M.
Economic Model Remains Robust Despite Challenges
The company confirms the robustness of its economic model with a nearly stable standard margin at 45.05% in 2025, compared to 45.50% in 2024, amounting to €4.9M. However, this raw solidity does not reflect in the operating results, which show a loss of €168K in 2025 compared to a profit of €462K the previous year. EBITDA fell from €0.68M to €0.51M, directly due to a €0.42M increase in payroll expenses linked to the recruitment of four new staff members at the beginning of 2025: an export assistant, two sales profiles, and a technical manager. These anticipated human investments, estimated at €0.54M for the fiscal year 2025, are the explicit counterbalance for a planned organizational ramp-up. If neutralized, these investments would bring EBITDA to €1.02M and net income to €0.42M.
Financial Structure Prepared for Strategic Deployment
As of December 31, 2025, NEOLIFE has a cash reserve of €1.45M, down by €0.42M from the start of the fiscal year, reflecting the investments made. Concurrently, the company reduced its debt by 37%, from €0.91M to €0.58M, which includes €0.2M from state-guaranteed loans, €0.037M from BPI innovation loans, and €0.34M from financing dedicated to production line investments. The scheduled repayments are €0.34M in 2026, then €0.10M in 2027, €0.11M in 2028, and €0.02M in 2029. This financial structure preserves the necessary leeway for the deployment of the strategic plan for 2026-2030. The immediate challenge for investors will be to ensure that the commercial ramp-up of the strengthened teams in 2025 translates into an acceleration of revenue from 2026, thus transforming the anticipated expenses into creators of sustainable value.
